News | Proton Therapy | February 04, 2016

University of Maryland School of Medicine Announces New Maryland Proton Alliance

Collaboration integrates proton therapy research, education and clinical care at new Maryland Proton Therapy Center

University of Maryland School of Medicine, UM SOM, Maryland Proton Alliance, MPA, proton therapy

February 4, 2016 — The University of Maryland School of Medicine (UM SOM) announced the establishment of the Maryland Proton Alliance (MPA), a new organizational framework for proton therapy that may serve as a national model for patient-centered cancer care.

The Alliance will be led by Zeljko Vujaskovic, M.D., Ph.D., professor in the Department of Radiation Oncology and head of the department’s Division of Translational Radiation Sciences. Vujaskovic succeeds Minesh Mehta, MBChB, who served as medical director of the Maryland Proton Treatment Center (MPTC) during its development from 2012 to 2015.

William F. Regine, MD, FACR, FACRO, Chairman of the Department of Radiation Oncology at the University of Maryland School of Medicine (UM SOM), along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, today announced the establishment of the Maryland Proton Alliance (MPA), a new organizational framework for proton therapy at UM SOM that may serve as a national model for patient-centered cancer care.

MPA is the result of long-term collaborative planning designed to make innovative research activities integral to the infrastructure of the new $200 million, 110,000-square-foot MPTC, which is now open and scheduled to begin treating patients in February. As part of its mission, the MPA brings together the multi-platform global research and education programs of the UM SOM with the clinical services of the MPTC — combining the resources of UM SOM and industry partner Advanced Particle Therapy LLC, with support from federal, industry, regional and global stakeholders.

“This is an extraordinary opportunity,” said Vujaskovic. “As the only proton treatment center in the Baltimore–Washington region, we are in a unique position to partner with a wide range of public and private researchers, many of whom are only beginning to assess the potential value of this technology and are eager to work with a premiere academic institution in these efforts.”

Over his career, Vujaskovic has developed diverse extramural partnerships and received funding from the National Institutes of Health, the Department of Defense, the Biomedical Advanced Research and Development Authority (BARDA), NASA and others. He is an internationally recognized investigator in radiation effects on normal and tumor tissue. He has clinical expertise in prostate and bladder cancer treatment and is currently a leader in the innovative use of thermal therapy (hyperthermia) for various malignancies. Under his direction, the Division of Translational Research Sciences has become a leader in collaborative studies investigating medical countermeasures to radiation.

The MPA will build on an existing strong track record of research relationships with major academic centers, industry and the federal government to create new programs exploring the benefits of protons in treating cancer. As a result, Vujaskovic anticipates that this unique alliance will increase research funding, as well as create new research positions and educational opportunities for graduate students and other trainees.

For more information: www.mdproton.com

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...